Pnc Financial Services Group, Inc. Aclaris Therapeutics, Inc. Transaction History

Pnc Financial Services Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$7.89 - $10.64 $1,467 - $1,979	186 Added 25.62%	912 $9,000
Q1 2023 May 15, 2023	BUY	$7.07 - $17.95 $5,132 - $13,031	726 New	726 $5,000
Q2 2020 Aug 07, 2020	SELL	$1.04 - $1.73 $87 - $145	-84 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$14.38 - $20.89 $141,197 - $205,118	-9,819 Reduced 99.15%	84 $0
Q2 2018 Aug 10, 2018	BUY	$16.46 - $20.33 $30,204 - $37,305	1,835 Added 22.74%	9,903 $0
Q1 2018 May 11, 2018	BUY	$17.08 - $25.64 $34 - $51	2 Added 0.02%	8,068 $0
Q4 2017 Feb 09, 2018	BUY	$21.47 - $27.8 $3,564 - $4,614	166 Added 2.1%	8,066 $0
Q3 2017 Nov 13, 2017	BUY	$23.02 - $28.8 $181,858 - $227,520	7,900	7,900 $0

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.